132 related articles for article (PubMed ID: 10400804)
21. Characterization of an adenovirus gene transfer vector containing an E4 deletion.
Armentano D; Sookdeo CC; Hehir KM; Gregory RJ; St George JA; Prince GA; Wadsworth SC; Smith AE
Hum Gene Ther; 1995 Oct; 6(10):1343-53. PubMed ID: 8590739
[TBL] [Abstract][Full Text] [Related]
22. Distinct roles of the Adenovirus E4 ORF3 protein in viral DNA replication and inhibition of genome concatenation.
Evans JD; Hearing P
J Virol; 2003 May; 77(9):5295-304. PubMed ID: 12692231
[TBL] [Abstract][Full Text] [Related]
23. Oncolytic adenovirus that overproduces ADP and replicates selectively in tumors due to hTERT promoter-regulated E4 gene expression.
Kuppuswamy M; Spencer JF; Doronin K; Tollefson AE; Wold WS; Toth K
Gene Ther; 2005 Nov; 12(22):1608-17. PubMed ID: 16034456
[TBL] [Abstract][Full Text] [Related]
24. Comparison of the human versus murine cytomegalovirus immediate early gene promoters for transgene expression by adenoviral vectors.
Addison CL; Hitt M; Kunsken D; Graham FL
J Gen Virol; 1997 Jul; 78 ( Pt 7)():1653-61. PubMed ID: 9225042
[TBL] [Abstract][Full Text] [Related]
25. Promoter strength in adenovirus transducing vectors: down-regulation of the adenovirus E1A promoter in 293 cells facilitates vector construction.
Schaack J; Allen B; Orlicky DJ; Bennett ML; Maxwell IH; Smith RL
Virology; 2001 Dec; 291(1):101-9. PubMed ID: 11878880
[TBL] [Abstract][Full Text] [Related]
26. Transactivation of adenovirus E2-early promoter by E1A and E4 6/7 in the context of viral chromosome.
Swaminathan S; Thimmapaya B
J Mol Biol; 1996 May; 258(5):736-46. PubMed ID: 8637006
[TBL] [Abstract][Full Text] [Related]
27. Efficient dual transcomplementation of adenovirus E1 and E4 regions from a 293-derived cell line expressing a minimal E4 functional unit.
Yeh P; Dedieu JF; Orsini C; Vigne E; Denefle P; Perricaudet M
J Virol; 1996 Jan; 70(1):559-65. PubMed ID: 8523570
[TBL] [Abstract][Full Text] [Related]
28. A gene transfer vector-cell line system for complete functional complementation of adenovirus early regions E1 and E4.
Brough DE; Lizonova A; Hsu C; Kulesa VA; Kovesdi I
J Virol; 1996 Sep; 70(9):6497-501. PubMed ID: 8709289
[TBL] [Abstract][Full Text] [Related]
29. Transforming potential of the adenovirus type 5 E4orf3 protein.
Nevels M; Täuber B; Kremmer E; Spruss T; Wolf H; Dobner T
J Virol; 1999 Feb; 73(2):1591-600. PubMed ID: 9882365
[TBL] [Abstract][Full Text] [Related]
30. Effects of first generation E1E3-deleted and second generation E1E3E4-deleted/modified adenovirus vectors on human endothelial cell death.
Jornot L; Petersen H; Lusky M; Pavirani A; Moix I; Morris ; Rochat T
Endothelium; 2001; 8(3):167-79. PubMed ID: 11824470
[TBL] [Abstract][Full Text] [Related]
31. High and sustained transgene expression in vivo from plasmid vectors containing a hybrid ubiquitin promoter.
Yew NS; Przybylska M; Ziegler RJ; Liu D; Cheng SH
Mol Ther; 2001 Jul; 4(1):75-82. PubMed ID: 11472109
[TBL] [Abstract][Full Text] [Related]
32. Adenovirus-mediated suicide gene therapy for bladder cancer: comparison of the cytomegalovirus- and Rous sarcoma virus-promoter.
Freund CT; Tong XW; Block A; Contant CF; Kieback DG; Rowley DR; Lerner SP
Anticancer Res; 2000; 20(5A):2811-6. PubMed ID: 11062688
[TBL] [Abstract][Full Text] [Related]
33. Detailed analysis of structures and formulations of cationic lipids for efficient gene transfer to the lung.
Lee ER; Marshall J; Siegel CS; Jiang C; Yew NS; Nichols MR; Nietupski JB; Ziegler RJ; Lane MB; Wang KX; Wan NC; Scheule RK; Harris DJ; Smith AE; Cheng SH
Hum Gene Ther; 1996 Sep; 7(14):1701-17. PubMed ID: 8886841
[TBL] [Abstract][Full Text] [Related]
34. Investigation of promoter function in human and animal cells infected with human recombinant adenovirus expressing rotavirus antigen VP7sc.
Xu ZZ; Krougliak V; Prevec L; Graham FL; Both GW
J Gen Virol; 1995 Aug; 76 ( Pt 8)():1971-80. PubMed ID: 7636477
[TBL] [Abstract][Full Text] [Related]
35. Characterization of factors involved in modulating persistence of transgene expression from recombinant adenovirus in the mouse lung.
Kaplan JM; Armentano D; Sparer TE; Wynn SG; Peterson PA; Wadsworth SC; Couture KK; Pennington SE; St George JA; Gooding LR; Smith AE
Hum Gene Ther; 1997 Jan; 8(1):45-56. PubMed ID: 8989994
[TBL] [Abstract][Full Text] [Related]
36. Reduced toxicity, attenuated immunogenicity and efficient mediation of human p53 gene expression in vivo by an adenovirus vector with deleted E1-E3 and inactivated E4 by GAL4-TATA promoter replacement.
Ji L; Bouvet M; Price RE; Roth JA; Fang B
Gene Ther; 1999 Mar; 6(3):393-402. PubMed ID: 10435089
[TBL] [Abstract][Full Text] [Related]
37. Open reading frames 1 and 2 of adenovirus region E4 are conserved between human serotypes 2 and 5.
Dix I; Leppard KN
J Gen Virol; 1992 Nov; 73 ( Pt 11)():2975-6. PubMed ID: 1431812
[TBL] [Abstract][Full Text] [Related]
38. Induction of transformation and p53-dependent apoptosis by adenovirus type 5 E4orf6/7 cDNA.
Yamano S; Tokino T; Yasuda M; Kaneuchi M; Takahashi M; Niitsu Y; Fujinaga K; Yamashita T
J Virol; 1999 Dec; 73(12):10095-103. PubMed ID: 10559324
[TBL] [Abstract][Full Text] [Related]
39. Long-term gene delivery into the livers of immunocompetent mice with E1/E4-defective adenoviruses.
Dedieu JF; Vigne E; Torrent C; Jullien C; Mahfouz I; Caillaud JM; Aubailly N; Orsini C; Guillaume JM; Opolon P; Delaere P; Perricaudet M; Yeh P
J Virol; 1997 Jun; 71(6):4626-37. PubMed ID: 9151856
[TBL] [Abstract][Full Text] [Related]
40. Early region 4 modulates adenovirus DNA replication by two genetically separable mechanisms.
Medghalchi S; Padmanabhan R; Ketner G
Virology; 1997 Sep; 236(1):8-17. PubMed ID: 9299612
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
